These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3340456)

  • 21. Infections in acute leukemia: an analysis of 240 febrile episodes.
    Jagarlamudi R; Kumar L; Kochupillai V; Kapil A; Banerjee U; Thulkar S
    Med Oncol; 2000 May; 17(2):111-6. PubMed ID: 10871816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of microbiology and antibiotic susceptibility in 131 cases of prosthetic hip infections].
    Sun C; Zhou Y; Chai W; Wang Y
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(21):1657-60. PubMed ID: 25152292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.
    Cortés JA; Cuervo S; Gómez CA; Bermúdez D; Martínez T; Arroyo P
    Biomedica; 2013; 33(1):70-7. PubMed ID: 23715309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
    N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infections in cancer patients with granulocytopenia. Retrospective studies of 59 febrile episodes with hospitalization].
    Ghosn M; Dagher E; Nasr F; Chahine G; Taleb N; Nasnas R; Ghayad E
    J Med Liban; 1994; 42(3):117-22. PubMed ID: 7629843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy.
    Morrison VA; Peterson BA; Bloomfield CD
    Med Pediatr Oncol; 1990; 18(3):209-16. PubMed ID: 2329966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Meropenem therapy in children with febrile neutropenia].
    Müller J; Kovács G; Garami M; Schmidt M; Fekete G
    Orv Hetil; 2003 Oct; 144(43):2115-20. PubMed ID: 14661443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
    Karlowicz MG; Buescher ES; Surka AE
    Pediatrics; 2000 Dec; 106(6):1387-90. PubMed ID: 11099593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Rizal AM; Nordiah AJ; Jamal R
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
    Hamzeh F; Kanj SS; Uwaydah M
    J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Scaglione C; López H; Fernández A; Marcenac F; Garay G; Dupont J; Pavlovsky S
    Medicina (B Aires); 1981; 41 Suppl():29-34. PubMed ID: 6954341
    [No Abstract]   [Full Text] [Related]  

  • 39. [Febrile neutropenia in children with cancer in a medical center of Santiago, Chile].
    Arnello L M; Quintana B JA; Barraza C P
    Rev Chilena Infectol; 2007 Feb; 24(1):27-32. PubMed ID: 17369967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.